What You Should Know
- Global laboratory informatics provider Clinisys officially unveiled its AI Innovation Roadmap, establishing an open, governed platform strategy designed to embed artificial intelligence, analytics, and workflow automation into routine laboratory operations.
- The roadmap articulates a compounding evolutionary progression that advances laboratory informatics across four distinct architectural phases: from a System of Record to a System of Workflow, a System of Intelligence, and ultimately an autonomous System of Orchestration.
- The operational paradigm enables clinical, diagnostic, and life sciences laboratories to mature through three distinct stages of technological capability: Inform (descriptive operational insights), Optimize (predictive analytics and instrument anomaly detection), and Transform (agentic workflow orchestration governed by human-in-the-loop oversight).
The Digital Maturity Progression: Compounding Laboratory Intelligence
The roadmap advances the Clinisys Connected Laboratory Intelligence value chain through a compounding maturity progression that shifts the laboratory from a static System of Record focused on descriptive insight, to a System of Workflow standardizing task execution, to a System of Intelligence optimizing operations via prediction and anomaly detection, and ultimately to an agentic System of Orchestration that executes workflows under human approval. CTO Shay Hassidim noted that this framework ensures every laboratory decision—from sequencing specimens to advancing therapeutic discovery—is informed by governed, generative AI grounded in trusted laboratory context while maintaining clinicians in full control.
Open Architecture Foundations: CLS MCP and No-Code Decisioning
Rather than locking healthcare organizations into a single proprietary ecosystem, Clinisys established two open foundation paths running on the Clinisys Laboratory Solution Extended API and shared platform services. The CLS Model Context Protocol foundation adopts the emerging MCP standard to allow advanced IT teams to safely connect approved enterprise AI assistants to governed laboratory information with strict organizational permissions, guardrails, and auditability. In parallel, the CLS NoCode AI foundation leverages pre-built components to let frontline lab teams configure automated, governed workflows—such as reflex testing, result verification, and corrective actions—without writing software code. These capabilities are intended to scale across a planned Clinisys AI Marketplace that will distribute certified agents, skills, and third-party extensions.
The broader strategy organizes shared AI capabilities into five targeted outcome domains, spanning embedded Workflow Copilots, conversational and predictive Advanced Analytics, automated specimen and turnaround-time Orchestration, the AI Marketplace, and an Intelligent Lab Command Center designed to unify instrument telemetry and agent oversight. Demonstrating this architecture in practice, Clinisys previewed two initial agent experiences: the Analytics Agent, which conversationally guides authorized personnel through asking, visualizing, analyzing, exporting, and scheduling governed datasets; and the Equipment Care Agent, which evaluates analyzer activity, quality-control metrics, and maintenance logs to detect mechanical issues early and eliminate avoidable test reruns. Director of AI Analytics and Agentic Platforms Prashant Prabudh emphasized that the ultimate advantage is not any single agent, but rather this open, governed intelligence layer that connects data, APIs, and workflows to sustain continuous operational innovation across the more than 7,000 laboratories Clinisys serves worldwide.
